Opinion

Despite the coronavirus crisis, business still goes on at some PE firms: Hillhouse is seeking to raise up to $13 billion for its next fund while HGGC is scouring for new M&A ventures.

PE firms move slowly into offense mode amid the coronavirus crisis and Thoma Bravo shelves its sale of Imprivata.

Despite the current coronavirus crisis, deals are being prepped.

Thomas Friedman recently argued that “the coronavirus will create a new historical divide: before-Corona (BC) and after-Corona (AC).”

COVID-19 crisis could bode well for new M&A tech opportunities and Gryphon launches sixth fund.

Amid the COVID-9 crisis, some firms are invoking the MAC clause to pull out of deals.

Thoma Bravo calls off its potential $2 billion-plus sale of Imprivata amid the coronavirus pandemic and New York State Common Retirement Fund commits to a $2 billion co-investment fund with Neuberger Berman.

MiddleGround is paying leave for employees who test positive for COVID-19 and trying to de-stress during a period of excessive stress.

Telehealth tackles the coronavirus and CapVest-backed Curium calls off its potential $3 billion sale.

Leonard Green partners commit $10 million for an employee-assistance fund and a placement agent is surprisingly optimistic about the long-term effects of the coronavirus outbreak on private equity fundraising